187 related articles for article (PubMed ID: 24324466)
1. MHC Class II Protein Turnover In vivo and Its Relevance for Autoimmunity in Non-Obese Diabetic Mice.
De Riva A; Busch R
Front Immunol; 2013 Nov; 4():399. PubMed ID: 24324466
[TBL] [Abstract][Full Text] [Related]
2. Accelerated turnover of MHC class II molecules in nonobese diabetic mice is developmentally and environmentally regulated in vivo and dispensable for autoimmunity.
De Riva A; Varley MC; Bluck LJ; Cooke A; Deery MJ; Busch R
J Immunol; 2013 Jun; 190(12):5961-71. PubMed ID: 23677470
[TBL] [Abstract][Full Text] [Related]
3. Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II:peptide complex modulate the progression of autoimmune diabetes.
Zhang L; Sosinowski T; Cox AR; Cepeda JR; Sekhar NS; Hartig SM; Miao D; Yu L; Pietropaolo M; Davidson HW
J Autoimmun; 2019 Jan; 96():50-58. PubMed ID: 30122420
[TBL] [Abstract][Full Text] [Related]
4. Targeted regulation of self-peptide presentation prevents type I diabetes in mice without disrupting general immunocompetence.
Yi W; Seth NP; Martillotti T; Wucherpfennig KW; Sant'Angelo DB; Denzin LK
J Clin Invest; 2010 Apr; 120(4):1324-36. PubMed ID: 20200448
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HLA-DM Mediated MHC Class II Peptide Loading by HLA-DO Promotes Self Tolerance.
Denzin LK
Front Immunol; 2013 Dec; 4():465. PubMed ID: 24381574
[TBL] [Abstract][Full Text] [Related]
6. Antigen presentation events during the initiation of autoimmune diabetes in the NOD mouse.
Ferris ST; Carrero JA; Unanue ER
J Autoimmun; 2016 Jul; 71():19-25. PubMed ID: 27021276
[TBL] [Abstract][Full Text] [Related]
7. A novel pathway of presentation by class II-MHC molecules involving peptides or denatured proteins important in autoimmunity.
Mohan JF; Unanue ER
Mol Immunol; 2013 Sep; 55(2):166-8. PubMed ID: 23200226
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.
Durinovic-Belló I
Autoimmunity; 1998; 27(3):159-77. PubMed ID: 9609134
[TBL] [Abstract][Full Text] [Related]
9. Genetic and therapeutic control of diabetogenic CD8+ T cells.
Santamaria P
Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitination by March-I prevents MHC class II recycling and promotes MHC class II turnover in antigen-presenting cells.
Cho KJ; Walseng E; Ishido S; Roche PA
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10449-54. PubMed ID: 26240324
[TBL] [Abstract][Full Text] [Related]
11. A TCR-like antibody against a proinsulin-containing fusion peptide ameliorates type 1 diabetes in NOD mice.
Matsumoto Y; Kishida K; Matsumoto M; Matsuoka S; Kohyama M; Suenaga T; Arase H
Biochem Biophys Res Commun; 2021 Jan; 534():680-686. PubMed ID: 33208230
[TBL] [Abstract][Full Text] [Related]
12. The pathway for MHCII-mediated presentation of endogenous proteins involves peptide transport to the endo-lysosomal compartment.
Dani A; Chaudhry A; Mukherjee P; Rajagopal D; Bhatia S; George A; Bal V; Rath S; Mayor S
J Cell Sci; 2004 Aug; 117(Pt 18):4219-30. PubMed ID: 15316082
[TBL] [Abstract][Full Text] [Related]
13. A self MHC class II beta-chain peptide prevents diabetes in nonobese diabetic mice.
Chaturvedi P; Agrawal B; Zechel M; Lee-Chan E; Singh B
J Immunol; 2000 Jun; 164(12):6610-20. PubMed ID: 10843721
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes.
Wicker LS; Appel MC; Dotta F; Pressey A; Miller BJ; DeLarato NH; Fischer PA; Boltz RC; Peterson LB
J Exp Med; 1992 Jul; 176(1):67-77. PubMed ID: 1613467
[TBL] [Abstract][Full Text] [Related]
15. Effect of interferon alpha on MHC class II gene expression in ex vivo human islet tissue.
Harris PE; Malanga D; Liu Z; Hardy MA; Souza F; Del Pozzo G; Winchester RJ; Maffei A
Biochim Biophys Acta; 2006 Jun; 1762(6):627-35. PubMed ID: 16782520
[TBL] [Abstract][Full Text] [Related]
16. MHC class I-mediated antigen presentation and induction of CD8+ cytotoxic T-cell responses in autoimmune diabetes-prone NOD mice.
Serreze DV; Gallichan WS; Snider DP; Croitoru K; Rosenthal KL; Leiter EH; Christianson GJ; Dudley ME; Roopenian DC
Diabetes; 1996 Jul; 45(7):902-8. PubMed ID: 8666141
[TBL] [Abstract][Full Text] [Related]
17. Development of an I-Ag7-expressing antigen-presenting cell line: intrinsic molecular defect in compact I-Ag7 dimer generation.
Nabavieh A; Chou H; Volokhov I; Lee JE; Purdy LE; Elliott JF; Singh B; Madrenas J
J Autoimmun; 1998 Feb; 11(1):63-71. PubMed ID: 9480724
[TBL] [Abstract][Full Text] [Related]
18. Transplantation of MHC-mismatched mouse embryonic stem cell-derived thymic epithelial progenitors and MHC-matched bone marrow prevents autoimmune diabetes.
Su M; Lin Y; He Z; Lai L
Stem Cell Res Ther; 2019 Aug; 10(1):239. PubMed ID: 31387620
[TBL] [Abstract][Full Text] [Related]
19. Induction of autoimmune diabetes in non-obese diabetic mice requires interleukin-21-dependent activation of autoreactive CD8⁺ T cells.
Chen XL; Bobbala D; Rodriguez GM; Mayhue M; Chen YG; Ilangumaran S; Ramanathan S
Clin Exp Immunol; 2013 Aug; 173(2):184-94. PubMed ID: 23607664
[TBL] [Abstract][Full Text] [Related]
20. On the perils of poor editing: regulation of peptide loading by HLA-DQ and H2-A molecules associated with celiac disease and type 1 diabetes.
Busch R; De Riva A; Hadjinicolaou AV; Jiang W; Hou T; Mellins ED
Expert Rev Mol Med; 2012 Jul; 14():e15. PubMed ID: 22805744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
